Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study

Mette Charlot; Lars Hougaard Nielsen; Jesper Lindhardsen; Ole Ahlehoff; Anne-Marie S Olsen; Morten Lock Hansen; Peter Riis Hansen; Jan Kyst Madsen; Lars Køber; Gunnar H Gislason; Christian Torp-Pedersen

doi:10.1093/eurheartj/ehs202

Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study

Mette Charlot, Lars Hougaard Nielsen, Jesper Lindhardsen, Ole Ahlehoff, Anne-Marie S Olsen, Morten Lock Hansen, Peter Riis Hansen, Jan Kyst Madsen, Lars Køber, Gunnar H Gislason, Christian Torp-Pedersen

18 Citationer (Scopus)

Abstract

The benefit of extending clopidogrel treatment beyond the 12-month period recommended in current guidelines after myocardial infarction (MI) is debated. We analysed the risk of adverse cardiovascular outcomes after discontinuation of 12 months of clopidogrel treatment.

Originalsprog	Engelsk
Tidsskrift	European Heart Journal (English Edition)
Vol/bind	33
Udgave nummer	20
Sider (fra-til)	2527-34
Antal sider	8
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehs202
Status	Udgivet - 2012

Adgang til dokumentet

10.1093/eurheartj/ehs202

Andre filer og links

Link to publication in Scopus

Citationsformater

Charlot, M., Nielsen, L. H., Lindhardsen, J., Ahlehoff, O., Olsen, A.-M. S., Hansen, M. L., Hansen, P. R., Madsen, J. K., Køber, L., Gislason, G. H., & Torp-Pedersen, C. (2012). Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study. European Heart Journal (English Edition), 33(20), 2527-34. https://doi.org/10.1093/eurheartj/ehs202

Charlot, M, Nielsen, LH, Lindhardsen, J , Ahlehoff, O , Olsen, A-MS , Hansen, ML , Hansen, PR, Madsen, JK, Køber, L , Gislason, GH & Torp-Pedersen, C 2012, 'Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study', European Heart Journal (English Edition), bind 33, nr. 20, s. 2527-34. https://doi.org/10.1093/eurheartj/ehs202

@article{74667024408746818062510de31e8fec,

title = "Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study",

abstract = "The benefit of extending clopidogrel treatment beyond the 12-month period recommended in current guidelines after myocardial infarction (MI) is debated. We analysed the risk of adverse cardiovascular outcomes after discontinuation of 12 months of clopidogrel treatment.",

author = "Mette Charlot and Nielsen, \{Lars Hougaard\} and Jesper Lindhardsen and Ole Ahlehoff and Olsen, \{Anne-Marie S\} and Hansen, \{Morten Lock\} and Hansen, \{Peter Riis\} and Madsen, \{Jan Kyst\} and Lars K{\o}ber and Gislason, \{Gunnar H\} and Christian Torp-Pedersen",

year = "2012",

doi = "10.1093/eurheartj/ehs202",

language = "English",

volume = "33",

pages = "2527--34",

journal = "European Heart Journal (English Edition)",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "20",

}

TY - JOUR

T1 - Clopidogrel discontinuation after myocardial infarction and risk of thrombosis

T2 - a nationwide cohort study

AU - Charlot, Mette

AU - Nielsen, Lars Hougaard

AU - Lindhardsen, Jesper

AU - Ahlehoff, Ole

AU - Olsen, Anne-Marie S

AU - Hansen, Morten Lock

AU - Hansen, Peter Riis

AU - Madsen, Jan Kyst

AU - Køber, Lars

AU - Gislason, Gunnar H

AU - Torp-Pedersen, Christian

PY - 2012

Y1 - 2012

N2 - The benefit of extending clopidogrel treatment beyond the 12-month period recommended in current guidelines after myocardial infarction (MI) is debated. We analysed the risk of adverse cardiovascular outcomes after discontinuation of 12 months of clopidogrel treatment.

AB - The benefit of extending clopidogrel treatment beyond the 12-month period recommended in current guidelines after myocardial infarction (MI) is debated. We analysed the risk of adverse cardiovascular outcomes after discontinuation of 12 months of clopidogrel treatment.

UR - https://www.scopus.com/pages/publications/84867714999

U2 - 10.1093/eurheartj/ehs202

DO - 10.1093/eurheartj/ehs202

M3 - Journal article

C2 - 22798561

SN - 0195-668X

VL - 33

SP - 2527

EP - 2534

JO - European Heart Journal (English Edition)

JF - European Heart Journal (English Edition)

IS - 20

ER -

Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater